who developed a dexamethasone-conjugated moiety combined with an anti-vitamin D binding protein siRNA formed into nanoparticles, which significantly reduced airway inflammation and other asthma-induced responses in ovalbumin sensitized mice [128]. This evidence concerns the gene GC and asthma.